The global view of replication stress provided by the repstress signature reveals heightened genomic instability, immune evasion, and poor survival in subsets of tumors across lineages, and enabled identification of cancer subtypes that may be more vulnerable to replication and replication stress response inhibitors including the novel ATR inhibitors (Fig. 4O; Supplementary Fig. S1). Here, ATR is linked to cancer.